Reliv' International (RELV) Competitors

Reliv' International (NASDAQ:RELV) and iBio (NYSE:IBIO) are both small-cap pharmaceutical preparations industry companies, but which is the better business? We will contrast the two businesses based on the strength of their institutional ownership, risk, earnings, valuation, media sentiment, profitability, analyst recommendations and dividends.

Which has more risk & volatility, RELV or IBIO?

Reliv' International has a beta of -0.1, meaning that its share price is 110% less volatile than the S&P 500. Comparatively, iBio has a beta of 0.89, meaning that its share price is 11% less volatile than the S&P 500.

Do insiders and institutionals have more ownership in RELV or IBIO?

8.0% of Reliv' International shares are held by institutional investors. Comparatively, 7.9% of iBio shares are held by institutional investors. 31.2% of Reliv' International shares are held by insiders. Comparatively, 2.8% of iBio shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Which has preferable earnings and valuation, RELV or IBIO?

Reliv' International has higher revenue and earnings than iBio.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Reliv' International	$35.06M	0.13	-$440K	N/A	N/A
iBio	$400K	45.22	-$24.91M	-$1.74	-0.51

Does the media favor RELV or IBIO?

In the previous week, iBio had 4 more articles in the media than Reliv' International. MarketBeat recorded 4 mentions for iBio and 0 mentions for Reliv' International. Reliv' International's average media sentiment score of 0.00 equaled iBio'saverage media sentiment score.

Company	Overall Sentiment
Reliv' International	Neutral
iBio	Neutral

Do analysts recommend RELV or IBIO?

iBio has a consensus price target of $3.50, indicating a potential upside of 291.94%. Given iBio's stronger consensus rating and higher probable upside, analysts plainly believe iBio is more favorable than Reliv' International.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Reliv' International	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
iBio	0 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	3.00

Is RELV or IBIO more profitable?

iBio has a net margin of 0.00% compared to Reliv' International's net margin of -0.61%. Reliv' International's return on equity of -1.89% beat iBio's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Reliv' International	-0.61%	-1.89%	-1.31%
iBio	N/A	-73.15%	-45.51%

Summary

iBio beats Reliv' International on 8 of the 14 factors compared between the two stocks.